硒蛋白对糖尿病小鼠血糖、Ca2+转运以及NO系统影响的实验研究

目的研究硒蛋白对糖尿病小鼠血糖、Ca2+转运及NO系统的调控作用.方法体重(20.3±1.7)g昆明种雄性小鼠,腹腔注射200mg/kgbw,2%的四氧嘧啶造糖尿病(DM)模型.实验分6组正常对照组(Ⅰ)、正常+硒蛋白组(Se 100μg/kgbw)(Ⅱ)、糖尿病对照组(Ⅲ)、DM+硒蛋白低剂量组(Se 100μg/kgbw)(Ⅳ)、DM+硒蛋白高剂量组(Se 300μg/kgbw)(Ⅴ)、DM+亚硒酸钠组(Se 100μg/kgbw)(Ⅵ).结果Ⅴ组血糖(20.4±6.3)mmol/L明显低于Ⅲ组(45.3±3.3)mmoi/L,P＜0.05;肾脏三磷酸腺苷酶(Ca2+-ATPase)活性,Ⅴ组0.90±0.5明显高于Ⅲ组(0.35±0.1)μmol/(h·mg prot),P＜0.05;一氧化氮合酶(NOS)活性,Ⅴ组(25.0±4.3)U/ml明显低于Ⅲ组(35.2±4.4)U/ml,P＜0.05.结论补硒剂量为Se 300μg/kgbw的硒蛋白能够显著的降低糖尿病小鼠血糖、提高肾脏Ca2+-ATPase活性和降低血浆NOS活性.

Effects of selenoprotein on blood glucose, Ca2+ transfer and NO system in diabetic mice

OBJECTIVE: To study the controlling effect of selenoprotein on blood glucose, Ca2+ transfer and NO system in diabetic mice. METHODS: Male Kunming mice of (20.3 +/- 1.7) g body weight were injected 200 mg/kg bw, 2% alloxan in abdomen to make diabetic model (DM), and were randomly divided into six groups: normal control group (I), normal + selenoprotein group(Se 100 microg/kg bw) (lI), DM control group (III), DM + lower dose selenoprotein group(Se 100 microg/kg bw) (IV), DM + higher dose selenoprotein group (Se 300 microg/kg bw) (V), DM + Na2SeO3 group (Se 100 microg/kg bw) (VI). RESULTS: The level of blood glucose in V group (20.4 +/- 6.3 mmol/L] were significantly lower than lII group(45.3 +/- 3.3) mmol/L P < 0.05. The activity of Ca(2+) -ATPase of kidney in V group (0.90 +/- 0.5 micromol/ (h x mg prot) is significantly higher than III group (0.35 +/- 0.1) micromol/(h x mg prot)] (P < 0.05, and the activity of NOS in V group (25.0 +/- 4.3) U/ml] is significantly lower than III group (35.2 +/- 4.4) U/ml] (P < 0.05). CONCLUSION: Selenoprotein that supplemented selenium doseis 300 microg Se/kg weight could significantly decrease blood glucose, increase the activities of Ca(2+) -ATPase on kidney and weaken the activities of plasma NOS in diabetic mice.